Legend Biotech (LEGN) EBT Margin Growth (3y) (2022 - 2025)
Legend Biotech (LEGN) EBT Margin Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,237.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -120.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | 48,473.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48,473.00 |
| Sep 30, 2025 | 29,560.00 |
| Jun 30, 2025 | 156,389.00 |
| Mar 31, 2025 | 1,338.00 |
| Dec 31, 2024 | 24,830.00 |
| Sep 30, 2024 | 66,350.00 |
| Jun 30, 2024 | 84,238.00 |
| Mar 31, 2024 | -6,292.00 |
| Dec 31, 2023 | 14,143.00 |
| Sep 30, 2023 | 50,573.00 |
| Jun 30, 2023 | 89,157.00 |
| Mar 31, 2023 | 10,702.00 |
| Dec 31, 2022 | -17,403.00 |
| Sep 30, 2022 | -15,270.00 |
| Jun 30, 2022 | -133,062.00 |